Malignancy and rheumatoid arthritis

被引:32
|
作者
Askling J. [1 ]
机构
[1] Clinical Epidemiology Unit M9:01, Department of Medicine Solna, Karolinska University Hospital Solna
关键词
Rheumatoid Arthritis; Cancer Risk; Abatacept; Cancer Occurrence; Rheumatoid Arthritis Treatment;
D O I
10.1007/s11926-007-0067-1
中图分类号
学科分类号
摘要
The occurrence of cancer is not an infrequent event in patients with rheumatoid arthritis (RA). Indeed, following diagnosis of RA at a typical age (55 years), one in five patients will be diagnosed with cancer. In the vast majority of such cases, the cancer has nothing to do with RA or its treatment; rather, it represents the "background" risk applicable to all humans. In some cases, the cancer occurs as a result of factors also associated with the risk of developing RA (eg, smoking), even though no direct link exists between the cancer and the RA. In a fraction of cases, however, the cancer is causally associated with the RA disease or its treatments. This review summarizes our current understanding of the occurrence of cancer in RA, possible links to RA disease and to traditional and newer RA treatments. Copyright © 2007 by Current Medicine Group LLC.
引用
收藏
页码:421 / 426
页数:5
相关论文
共 50 条
  • [31] Nursing Considerations for Infusion Therapy in Rheumatoid Arthritis Versus Malignancy
    Furfaro, Nicole
    Mease, Philip J.
    JOURNAL OF INFUSION NURSING, 2008, 31 (06) : 350 - 360
  • [32] The Clinical and Laboratory Features of Seronegative Rheumatoid Arthritis with and Without Malignancy
    Higashida-Konishi, Misako
    Izumi, Keisuke
    Hama, Satoshi
    Takei, Hiroshi
    Okano, Yutaka
    Ohshima, Hisaji
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [33] MALIGNANCY IN THE UPADACITINIB CLINICAL TRIAL PROGRAMS FOR RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS
    Rubbert-Roth, Andrea
    Kakehasi, Adriana
    Takeuchi, Tsutomu
    Schmalzing, Marc
    Palac, Hannah
    Liu, Jianzhong
    Anyanwu, Samuel
    Lippe, Ralph
    Nash, Peter
    Curtis, Jeffrey
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 44 - 44
  • [34] Malignancy in the Upadacitinib Clinical Trial Programs for Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
    Rubbert-Roth, Andrea
    Kakehasi, Adriana
    Takeuchi, Tsutomu
    Schmalzing, Marc
    Palac, Hannah
    Liu, Jianzhong
    Anyanwu, Samuel
    Lippe, Ralph
    Curtis, Jeffrey
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 562 - 564
  • [35] The rheumatoid arthritis azathioprine registry (RAAR) - Interim analysis of malignancy and mortality
    Hickey, A
    Urowitz, M
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1521 - 1521
  • [36] A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis
    Smitten, Allison L.
    Simon, Teresa A.
    Hochberg, Marc C.
    Suissa, Samy
    ARTHRITIS RESEARCH & THERAPY, 2008, 10 (02)
  • [37] Malignancy Data in Tofacitinib-Treated Japanese Patients with Rheumatoid Arthritis
    Tanaka, Yoshiya
    Takeuchi, Tsutomu
    Yamanaka, Hisashi
    Sugiyama, Naonobu
    Yoshinaga, Takunari
    Togo, Kanae
    Geier, Jamie
    Boy, Mary
    Connell, Carol
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [38] MALIGNANCY DATA IN TOFACITINIB-TREATED JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS
    Tanaka, Y.
    Takeuchi, T.
    Yamanaka, H.
    Sugiyama, N.
    Yoshinaga, T.
    Togo, K.
    Geier, J.
    Boy, M.
    Connell, C. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 263 - 263
  • [39] When rheumatoid arthritis meets malignancy, what do we do?
    Li, Yixuan
    Wang, Jing
    Zhang, Ju
    Jiang, Huan
    Liu, Aihui
    Ying, Zhenhua
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (03)
  • [40] Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis
    Teresa A. Simon
    Adam Thompson
    Kunal K. Gandhi
    Marc C. Hochberg
    Samy Suissa
    Arthritis Research & Therapy, 17